Manufacturing and Production
Teva to lay off 236 in Pomona, New York
August 30, 2016 Manufacturing and Production, Research and Development Teva, closure
Heart disease drug development is falling
August 30, 2016 Manufacturing and Production, Research and Development cardiovascular disease, heart disease, research and development
Cipla receives FDA approval for generic version of Valeant antidepressant
August 30, 2016 Manufacturing and Production, Sales and Marketing Cipla, FDA, Valeant, Wellbutrin
Amgen’s Prolia achieves positive top-line Phase III results after 12 months
August 30, 2016 Manufacturing and Production, Research and Development Amgen, Prolia, denosumab, phase III
Sanofi & Regeneron’s Praluent cholesterol treatment smashes Phase III target
August 30, 2016 Manufacturing and Production, Research and Development Regeneron, Sanofi, apheresis, cholesterol, phase III
Vectura asthma treatment fails at Phase III
August 30, 2016 Manufacturing and Production, Research and Development asthma, inhaler, phase III, phase III failure, vectura
Top ten stories in the pharmaceutical industry this week
August 26, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top 10
Jobs to go at Takeda as it shuts down Cambridge facility
August 26, 2016 Manufacturing and Production, Medical Communications Cambridge, Jobs, Takeda, closure
Teva loses patent protection on lucrative MS treatment
August 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, Mylan, Teva, multiple sclerosis
Foundation Medicine adds new immunotherapy features to its gene profiling products
August 23, 2016 Manufacturing and Production, Research and Development FoundationOne, oncology, tumour
Roche launches ‘next-generation’ blood glucose monitoring system
August 23, 2016 Manufacturing and Production, Sales and Marketing Roche, blood glucose monitoring, diabetes
Bayer’s CRISPR venture opens for business in biotech hub
August 23, 2016 Manufacturing and Production, Research and Development Bayer, casebia, crispr, gene editing, gene-editing
Gilead gets EU approval for HIV-prevention treatment Truvada
August 23, 2016 Manufacturing and Production, Sales and Marketing EU, Gilead, HIV, PrEP, Truvada, prevention
Valeant appoints new executive VP of finance and CFO
August 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Valeant, appointment
FDA fast tracks Alzheimer’s drug from Lilly, AstraZeneca
August 22, 2016 Manufacturing and Production, Research and Development Alzheimer's disease, AstraZeneca, BACE, lilly, phase III
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
